Keren BaruchAssociateSheppard, Mullin, Richter & Hampton LLPWebsitewww.sheppardmullin.comOrganization ProfileFull ProfileBlogwww.sheppardmullin.com/publicationsConnectEmailTwitterLinkedIn212-896-0655 Professional Biography Keren Baruch is an associate in the Corporate Practice Group in the firm's New York office. PRACTICES Corporate Healthcare More Legal and Business Bylines From Keren Baruch Connecticut Follows in the Footsteps of Other Jurisdictions Requiring Registration of Pharmaceutical Representatives - (Posted On Wednesday, October 25, 2023) FDA Update: The Latest on Vaccine Development, Inspections, and Conducting Clinical Trials During Covid-19 - (Posted On Friday, September 25, 2020) Current Legal Analysis Breaking Down Federal Policies to Address Drug Shortages by: McDermott + Consulting PPPlease Stop Fraud: Two Whistleblowers Awarded $2.5 Million in PPP Fraud Settlement by: Tycko & Zavareei Whistleblower Practice Group On July 1, 2024, Texas May Have the Strongest Consumer Data Privacy Law in the United States by: Elizabeth Rogers 10 Creative Ways for Lawyers to Repurpose Content by: Stefanie M. Marrone FDA Gets Technical on HCT/P Rules in Warning Letter to Human Tissue Company by: Dominick DiSabatino , Cortney Inman Upcoming Legal Education Events Jun 26 2024 TSCA Reform — Eight Years Later Jun 18 2024 There Is More to TSCA Reporting Than CDR: TSCA Sections 8(a), (c), (d), and (e) Jun 12 2024 Preparing for HHS’s 340B Administrative Dispute Resolution (“ADR”) Reboot – Lessons from the Field Jun 12 2024 Sponsor’s Role in Regulatory Testing — Complying with GLP Standards Print